Showing results (1211-1220 of 6,843) with videos related to
Sort By:
Pageof 685
Archives of Toxicology|June 8, 2026
Mechanistic investigation of the hepatotoxicity and potential carcinogenicity of microcystin-LR, -LA, and -RR in the HepaRG cell line modelEnzo Zini Moreira Silva, Sahra Kiessig, Ilinca Suciu, et al.Archives of Toxicology|April 13, 2026
Distinct Ca2+ pools regulate NADPH oxidase 2 activation driving Ca2+-independent mitochondrial ROS formation and mitochondrial permeability transition in arsenic trioxide-treated NB4 cellsAndrea Guidarelli, Andrea Spina, Gloria Buffi, et al.Archives of Toxicology|May 1, 2026
Implementation of growth curves in a generic physiologically based kinetic model with a case study of perfluorooctanesulfonic acid (PFOS) in beef cattle, sheep, and chickenDavid Inauen, Leonie Sophie Lautz, Aalbert Jan Hendriks, et al.Archives of Toxicology|April 25, 2026
Effect biomonitoring in a controlled firefighting setting: an untargeted metabolomic pilot studyMax-Philipp Boehler, Christian Kersch, Bernd Rossbach, et al.Archives of Toxicology|May 5, 2026
Real-life nanoplastics induce endothelial dysfunction in primary human endothelial cellsJoan Martín-Pérez, Michelle Morataya-Reyes, Aliro Villacorta, et al.Archives of Toxicology|May 5, 2026
Mitochondrial lipid remodeling in sepsis-associated acute kidney injury: a cardiolipin-centered convergence frameworkTingkun Ma, Pan Zhai, Shiwei Ning, et al.Archives of Toxicology|March 31, 2026
The toxicity of psychedelic LSD derivatives: 1-acetyl-LSD (ALD-52), 1-propionyl-LSD (1P-LSD), 1-butyryl-LSD (1B-LSD), 1-valeryl-LSD (1V-LSD) and 1-cyclopropylmethanoyl-LSD (1cP-LSD)-prediction of toxicological parameters relevant to clinical and forensic toxicology using multi-in silico approachKamil Jurowski, Alicja Krośniak, Damian Kobylarz, et al.Archives of Toxicology|March 31, 2026
High-throughput PBK modelling for dermal exposure: a pragmatic approach to predict systemic pharmacokineticsZeynep Edizcan, Stephan Schaller, Lars Kuepfer, et al.Archives of Toxicology|May 13, 2026
Rosiglitazone hepatotoxicity resulting from hepatic protein covalent binding derived from its aldehyde metaboliteYanjia Zhao, Yi Yang, Zifang Ding, et al.Archives of Toxicology|May 13, 2026
From animal models to NAMs: a paradigm shift in developmental immunotoxicity testingMartina Iulini, Véronique de Bruijn, Selma Hurem, et al.Pageof 685